MedTrace Pharma A/S
CVR 36497661 · Public limited company (A/S) · Active · Medium risk
MedTrace Pharma A/S is a Public limited company (A/S), founded on , based in Hørsholm. The company is registered in the industry udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. 11 annual reports have been published. CEO: Lykke Jul Rømer.
Bankruptcy risk for MedTrace Pharma A/S
1.1 × the average (1.41%) · higher risk than 79% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 36497661
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (11 years)
- Address
- Agern Alle 5A
2970 Hørsholm - Municipality
- Rudersdal
- Industry
- Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events (773910)
Bankruptcies in the industry: Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver i.a.n. - Share capital
- DKK 16.1m
- Employees
- 8 (2018)
- Auditor
- KPMG P/S
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 11 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 8 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 50 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|
Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · KPMGStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 133 | ||
| 1 Jan 2024 – 31 Dec 2024 | 148 | ||
| 1 Jan 2023 – 31 Dec 2023 | 129 | ||
| 1 Jan 2022 – 31 Dec 2022 | 163 | ||
| 1 Jan 2021 – 31 Dec 2021 | 167 | ||
| 1 Jan 2020 – 31 Dec 2020 | 161 | ||
| 1 Jan 2019 – 31 Dec 2019 | 174 | ||
| 1 Jan 2018 – 31 Dec 2018 | 132 | ||
| 1 Jan 2017 – 31 Dec 2017 | 150 | ||
| 1 Jan 2016 – 31 Dec 2016 | 131 | ||
| 5 Jan 2015 – 31 Dec 2015 | 140 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Lykke Jul Rømer | Current | |
| CEO | Peter Larsen | ||
| CEO | Rune Wiik Kristensen | ||
| CEO | Rune Wiik Kristensen | ||
| CEO | Ann Kristin Brøgger Led | ||
| CEO | Lars Trolle | ||
| Board | Jens Hesthaven Sørensen | Current | |
| Board | Cesare Orlandi | Current | |
| Board | Claus Henrik Berner Møller | Current | |
| Board | Erik Anders Strömqvist | Current | |
| Board | Charlotte Vindfeldt | Current | |
| Board | Ellen Rietmann Ahl | Current | |
| Board | Bjarne Henning Jensen | ||
| Board | Mads Spangaard Rasmussen | ||
| Board | Bernt Skov Jensen | ||
| Board | Lenna Maria Boe Broberg | ||
| Board | Ulrik Spork | ||
| Board | Michael Frank | ||
| Board | Erik Anders Strömqvist | ||
| Board | Claus Henrik Berner Møller | ||
| Board | Erik Anders Strömqvist | ||
| Board | Robert Karl Schier | ||
| Board | Claus Henrik Berner Møller | ||
| Board | Erik Anders Strömqvist | ||
| Board | Peter Juul Kristensen | ||
| Owner (10%) | Swisscanto Private Equity I KmGK | Current | |
| Owner (5%) | Fund Investments S.A. SICAV-RAIF - Verve Venture Fund I | Current | |
| Owner (33%) | Arbejdsmarkedets Tillægspension | Current | |
| Owner (15%) | MedTravest IV ApS | Current | |
| Owner (33%) | Martin Dal Stenfeldt | ||
| Owner (33%) | SCANSYS HOLDING ApS | ||
| Owner (33%) | WIIK INVEST ApS | ||
| Owner (33%) | WASABI-LINK Holding ApS | ||
| Owner (20%) | Styrelsen for Forskning og Uddannelse | ||
| Owner (15%) | SCANSYS HOLDING ApS | ||
| Owner (25%) | FONDEN FOR SYDDANSK VÆKSTFREMME | ||
| Owner (15%) | WIIK INVEST ApS | ||
| Owner (15%) | WASABI-LINK Holding ApS | ||
| Owner (20%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (10%) | SCANSYS HOLDING ApS | ||
| Owner (15%) | FONDEN FOR SYDDANSK VÆKSTFREMME | ||
| Owner (10%) | WIIK INVEST ApS | ||
| Owner (10%) | WASABI-LINK Holding ApS | ||
| Owner (5%) | MedTravest A/S | ||
| Owner (15%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (5%) | SCANSYS HOLDING ApS | ||
| Owner (10%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (5%) | WIIK INVEST ApS | ||
| Owner (5%) | WASABI-LINK Holding ApS | ||
| Owner (10%) | Arbejdsmarkedets Tillægspension | ||
| Owner (10%) | FONDEN FOR SYDDANSK VÆKSTFREMME | ||
| Owner (5%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (5%) | WASABI-LINK Holding ApS | ||
| Owner (5%) | Swisscanto Private Equity I KmGK | ||
| Owner (5%) | EIC Fund | ||
| Owner (25%) | Arbejdsmarkedets Tillægspension | ||
| Owner (5%) | FONDEN FOR SYDDANSK VÆKSTFREMME | ||
| Owner (5%) | MedTravest IV ApS | ||
| Owner (5%) | Kapitalforeningen BankInvest Select | ||
| Owner (10%) | MedTravest IV ApS | ||
| Auditor | KPMG P/S | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Martin Dal Stenfeldt | Current | |
| Founder | SCANSYS HOLDING ApS | Current | |
| Founder | WIIK INVEST ApS | Current |
The CEOs' other companies
Lykke Jul Rømer – 5 other companies
- ALL-LOK ApS Active
- ALL-LOK HOLDING ApS Fusioneret
- ZP GENERAL PARTNER 1 ApS Active
- ZP GENERAL PARTNER 2 ApS Active
- ZP General Partner 3 ApS Active
Peter Larsen – 2 other companies
- SCANSYS HOLDING ApS Active
- SCANSYS LABORATORIETEKNIK ApS Active
Rune Wiik Kristensen – 2 other companies
- Tetrakit Technologies ApS Active
- WIIK PHARMA ApS Active
Ann Kristin Brøgger Led – 1 other companies
- SYNACT PHARMA ApS Active
Lars Trolle – 16 other companies, of which 3 bankrupt
- BIOTECH AF 14. MAJ 2014 ApS Bankrupt 24 Mar 2015
- DDD-DIAGNOSTIC A/S Bankrupt 13 Jun 2023
- EJENDOMSSELSKABET STAKTOFTEN 22 ApS Bankrupt 12 Jan 2015
- CONTURA A/S Active
- CONTURA INTERNATIONAL A/S Active
- CONTURA PROPERTIES A/S Active
- CURASIGHT A/S Active
- GRØNDAHL HOLDING A/S Active
- JILA COACHING ApS Active
- LT 2003 ApS Active
- LUXUM A/S Compulsorily dissolved
- NUKE HOLDING ApS Opløst
- Oolog ApS Active
- SPT Vilecon A/S Active
- TOTAX - PLASTIC A/S Opløst
- Trolle Care A/S Active
Address history (3 moves)
| Agern Alle 5A, 2970 Hørsholm | |
| Diplomvej 381, 2800 Kongens Lyngby | |
| Gotlandsvej 5, 5700 Svendborg | |
| Kløvereng 8, 2950 Vedbæk |
Former names
| MedTrace Pharma A/S | – now |
| MedTrace A/S | – |
| Medtrace ApS | – |
| LSW MEDICAL IVS | – |
Employees per year
Other companies at the same address
- LAROMINI ApS Bankrupt
- MyBlueLabel Compliance Services A/S Bankrupt
- NLR Invest ApS Bankrupt
- Selskabet af 9. juli 2026 ApS Bankrupt
- AML Christensen ApS Active
- ANALOG DEVICES A/S Active
- AQOOLA A/S Active
- Arkin ApS Active
- BAWAT A/S Active
- BBB 0401 ApS Active
- Bawat Technology Services ApS Opløst
- CM-AQUA, TECHNOLOGIES ApS Active
- CPHDevelopers ApS Active
- ChargeAdmin ApS Opløst
- DHI A/S Active
- DHI GRAS A/S Opløst
- DHI INVEST ApS Active
- DHI MUSE A/S Active
- DHI TOXISPOT A/S Active
- DTU Science Park a/s Active
- Decision Risk Analytics ApS Active
- Detalo Health ApS Active
- ECO REACTOR ApS Opløst
- EYE-GO A/S Active
- EYE-GO LABS ApS Active
Similar companies in Rudersdal
- SMT House ApS Vedbæk
- Tent Easy Up ApS Nærum
- Rhedd ApS Nærum
- Outdoorworks ApS Skodsborg
- Cheesewheels ApS Birkerød
- Nawi Rental ApS Birkerød
- RUDERSDAL UDLEJNING ApS Birkerød
- F.F INVEST A/S Birkerød
- FRANCHISE FINANCE NORDIC ApS Hørsholm
- YBH EJENDOMME ApS Birkerød
- WESTCON HOLDING ApS Vedbæk
- SKAGA INVEST ApS Vedbæk
Questions and answers about MedTrace Pharma A/S
Has MedTrace Pharma A/S gone bankrupt?
No, MedTrace Pharma A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of MedTrace Pharma A/S?
Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.
Who is the CEO of MedTrace Pharma A/S?
Lykke Jul Rømer is the CEO of MedTrace Pharma A/S.
Who is the auditor of MedTrace Pharma A/S?
MedTrace Pharma A/S most recently used KPMG P/S.
When was MedTrace Pharma A/S founded?
MedTrace Pharma A/S was founded on 5 January 2015.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.